MOLECULAR THERAPY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2092759, encodeId=fafb2092e594a, content=垃圾杂志，慎投！ 2022年3月份第一次投稿，一周送审，一个月拒。根据意见补了很多实验基本上都补了。 2022年9月再投，两周才到编辑手里，再过了两周直接拒。耽搁一个月，垃圾杂志，编辑没什么水准，大家慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b45477596, createdName=ms9000001700710365, createdTime=Sun Oct 09 23:30:42 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092124, encodeId=87812092124ee, content=“decision in process ”状态持续两个月了，目前状态仍没变，我也醉了，太慢了，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/9FvfglcsAUhibbMfzXkaojIdbGAyJoDbfzcwdBibkRB0zfCnoHNsKeU3FhVGfibEvAOU0MJib8YXDz0ozRRLq0MDZw/132, createdBy=b1175246524, createdName=Lily’s, createdTime=Thu Oct 06 19:22:56 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089721, encodeId=4bb42089e2180, content=请问这个杂志从起投到接收一般多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcbb6495932, createdName=ms9000001442827569, createdTime=Thu Sep 22 09:45:41 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573502, encodeId=30fa5e3502b4, content=我的文章投出去十几天才送审稿，审稿已经快一个月了，想问问大神们大概审稿要多久啊，要不要发邮件问问？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdcc5116745, createdName=大帅比, createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186366, encodeId=6a15118636612, content=请问大家投稿后不确认作者信息，影响稿件处理进程吗？？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/d83e222ca83744579abc7ae60aec94b4/d3ddb54b1ac74080bbe927391f78ad1a.jpg, createdBy=36415493698, createdName=志志呀, createdTime=Thu Jan 20 10:08:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187450, encodeId=3e3c118e4501a, content=提交之后多久能到编辑手里啊 Manuscript Submitted快一星期了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75b2502321, createdName=云墨天青, createdTime=Sun Jan 23 13:24:39 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192018, encodeId=3e05119201862, content=审稿速度:6.0 经验分享：已经under review 3个月了，还是没有结果，最近这个杂志审稿这么慢吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6202174197, createdName=1205b465m15(暂无昵称), createdTime=Thu Feb 10 21:02:47 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192581, encodeId=ef2c1192581eb, content=请问投完稿是要等所有作者确认后才能开始审稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoia8XBibt7nbkfNowiberE3oPQDI0UaP5xKwibkVjYXyypsTh8ZPqqkQqicDpto5CjtKHdO3keDQf399w/132, createdBy=54a378415, createdName=Tacid, createdTime=Sat Feb 12 06:57:12 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924446, encodeId=e1b8924446a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：审稿速度较快，reviewer非常专业和犀利，每个问题都一针见血。修稿时间充裕，只要努力满足reviewer所有意见，应该问题不大。editor稍稍有点磨蹭但很友好。ASGCT的official journal，21年2月即时IF已经10.9了，希望IF节节高升, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Sat Feb 13 13:50:38 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224804, encodeId=54de1224804f2, content=molecular therapy在肿瘤口碑怎么样？难度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Mon Jun 06 19:59:44 CST 2022, time=2022-06-06, status=1, ipAttribution=)]

2022-10-09 ms9000001700710365

垃圾杂志，慎投！ 2022年3月份第一次投稿，一周送审，一个月拒。根据意见补了很多实验基本上都补了。 2022年9月再投，两周才到编辑手里，再过了两周直接拒。耽搁一个月，垃圾杂志，编辑没什么水准，大家慎投。

44 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092759, encodeId=fafb2092e594a, content=垃圾杂志，慎投！ 2022年3月份第一次投稿，一周送审，一个月拒。根据意见补了很多实验基本上都补了。 2022年9月再投，两周才到编辑手里，再过了两周直接拒。耽搁一个月，垃圾杂志，编辑没什么水准，大家慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b45477596, createdName=ms9000001700710365, createdTime=Sun Oct 09 23:30:42 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092124, encodeId=87812092124ee, content=“decision in process ”状态持续两个月了，目前状态仍没变，我也醉了，太慢了，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/9FvfglcsAUhibbMfzXkaojIdbGAyJoDbfzcwdBibkRB0zfCnoHNsKeU3FhVGfibEvAOU0MJib8YXDz0ozRRLq0MDZw/132, createdBy=b1175246524, createdName=Lily’s, createdTime=Thu Oct 06 19:22:56 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089721, encodeId=4bb42089e2180, content=请问这个杂志从起投到接收一般多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcbb6495932, createdName=ms9000001442827569, createdTime=Thu Sep 22 09:45:41 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573502, encodeId=30fa5e3502b4, content=我的文章投出去十几天才送审稿，审稿已经快一个月了，想问问大神们大概审稿要多久啊，要不要发邮件问问？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdcc5116745, createdName=大帅比, createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186366, encodeId=6a15118636612, content=请问大家投稿后不确认作者信息，影响稿件处理进程吗？？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/d83e222ca83744579abc7ae60aec94b4/d3ddb54b1ac74080bbe927391f78ad1a.jpg, createdBy=36415493698, createdName=志志呀, createdTime=Thu Jan 20 10:08:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187450, encodeId=3e3c118e4501a, content=提交之后多久能到编辑手里啊 Manuscript Submitted快一星期了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75b2502321, createdName=云墨天青, createdTime=Sun Jan 23 13:24:39 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192018, encodeId=3e05119201862, content=审稿速度:6.0 经验分享：已经under review 3个月了，还是没有结果，最近这个杂志审稿这么慢吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6202174197, createdName=1205b465m15(暂无昵称), createdTime=Thu Feb 10 21:02:47 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192581, encodeId=ef2c1192581eb, content=请问投完稿是要等所有作者确认后才能开始审稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoia8XBibt7nbkfNowiberE3oPQDI0UaP5xKwibkVjYXyypsTh8ZPqqkQqicDpto5CjtKHdO3keDQf399w/132, createdBy=54a378415, createdName=Tacid, createdTime=Sat Feb 12 06:57:12 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924446, encodeId=e1b8924446a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：审稿速度较快，reviewer非常专业和犀利，每个问题都一针见血。修稿时间充裕，只要努力满足reviewer所有意见，应该问题不大。editor稍稍有点磨蹭但很友好。ASGCT的official journal，21年2月即时IF已经10.9了，希望IF节节高升, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Sat Feb 13 13:50:38 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224804, encodeId=54de1224804f2, content=molecular therapy在肿瘤口碑怎么样？难度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Mon Jun 06 19:59:44 CST 2022, time=2022-06-06, status=1, ipAttribution=)]

2022-10-06 Lily’s

“decision in process ”状态持续两个月了，目前状态仍没变，我也醉了，太慢了，太慢了

77 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092759, encodeId=fafb2092e594a, content=垃圾杂志，慎投！ 2022年3月份第一次投稿，一周送审，一个月拒。根据意见补了很多实验基本上都补了。 2022年9月再投，两周才到编辑手里，再过了两周直接拒。耽搁一个月，垃圾杂志，编辑没什么水准，大家慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b45477596, createdName=ms9000001700710365, createdTime=Sun Oct 09 23:30:42 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092124, encodeId=87812092124ee, content=“decision in process ”状态持续两个月了，目前状态仍没变，我也醉了，太慢了，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/9FvfglcsAUhibbMfzXkaojIdbGAyJoDbfzcwdBibkRB0zfCnoHNsKeU3FhVGfibEvAOU0MJib8YXDz0ozRRLq0MDZw/132, createdBy=b1175246524, createdName=Lily’s, createdTime=Thu Oct 06 19:22:56 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089721, encodeId=4bb42089e2180, content=请问这个杂志从起投到接收一般多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcbb6495932, createdName=ms9000001442827569, createdTime=Thu Sep 22 09:45:41 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573502, encodeId=30fa5e3502b4, content=我的文章投出去十几天才送审稿，审稿已经快一个月了，想问问大神们大概审稿要多久啊，要不要发邮件问问？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdcc5116745, createdName=大帅比, createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186366, encodeId=6a15118636612, content=请问大家投稿后不确认作者信息，影响稿件处理进程吗？？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/d83e222ca83744579abc7ae60aec94b4/d3ddb54b1ac74080bbe927391f78ad1a.jpg, createdBy=36415493698, createdName=志志呀, createdTime=Thu Jan 20 10:08:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187450, encodeId=3e3c118e4501a, content=提交之后多久能到编辑手里啊 Manuscript Submitted快一星期了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75b2502321, createdName=云墨天青, createdTime=Sun Jan 23 13:24:39 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192018, encodeId=3e05119201862, content=审稿速度:6.0 经验分享：已经under review 3个月了，还是没有结果，最近这个杂志审稿这么慢吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6202174197, createdName=1205b465m15(暂无昵称), createdTime=Thu Feb 10 21:02:47 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192581, encodeId=ef2c1192581eb, content=请问投完稿是要等所有作者确认后才能开始审稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoia8XBibt7nbkfNowiberE3oPQDI0UaP5xKwibkVjYXyypsTh8ZPqqkQqicDpto5CjtKHdO3keDQf399w/132, createdBy=54a378415, createdName=Tacid, createdTime=Sat Feb 12 06:57:12 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924446, encodeId=e1b8924446a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：审稿速度较快，reviewer非常专业和犀利，每个问题都一针见血。修稿时间充裕，只要努力满足reviewer所有意见，应该问题不大。editor稍稍有点磨蹭但很友好。ASGCT的official journal，21年2月即时IF已经10.9了，希望IF节节高升, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Sat Feb 13 13:50:38 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224804, encodeId=54de1224804f2, content=molecular therapy在肿瘤口碑怎么样？难度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Mon Jun 06 19:59:44 CST 2022, time=2022-06-06, status=1, ipAttribution=)]

2022-09-22 ms9000001442827569

请问这个杂志从起投到接收一般多长时间呀

48 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092759, encodeId=fafb2092e594a, content=垃圾杂志，慎投！ 2022年3月份第一次投稿，一周送审，一个月拒。根据意见补了很多实验基本上都补了。 2022年9月再投，两周才到编辑手里，再过了两周直接拒。耽搁一个月，垃圾杂志，编辑没什么水准，大家慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b45477596, createdName=ms9000001700710365, createdTime=Sun Oct 09 23:30:42 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092124, encodeId=87812092124ee, content=“decision in process ”状态持续两个月了，目前状态仍没变，我也醉了，太慢了，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/9FvfglcsAUhibbMfzXkaojIdbGAyJoDbfzcwdBibkRB0zfCnoHNsKeU3FhVGfibEvAOU0MJib8YXDz0ozRRLq0MDZw/132, createdBy=b1175246524, createdName=Lily’s, createdTime=Thu Oct 06 19:22:56 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089721, encodeId=4bb42089e2180, content=请问这个杂志从起投到接收一般多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcbb6495932, createdName=ms9000001442827569, createdTime=Thu Sep 22 09:45:41 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573502, encodeId=30fa5e3502b4, content=我的文章投出去十几天才送审稿，审稿已经快一个月了，想问问大神们大概审稿要多久啊，要不要发邮件问问？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdcc5116745, createdName=大帅比, createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186366, encodeId=6a15118636612, content=请问大家投稿后不确认作者信息，影响稿件处理进程吗？？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/d83e222ca83744579abc7ae60aec94b4/d3ddb54b1ac74080bbe927391f78ad1a.jpg, createdBy=36415493698, createdName=志志呀, createdTime=Thu Jan 20 10:08:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187450, encodeId=3e3c118e4501a, content=提交之后多久能到编辑手里啊 Manuscript Submitted快一星期了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75b2502321, createdName=云墨天青, createdTime=Sun Jan 23 13:24:39 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192018, encodeId=3e05119201862, content=审稿速度:6.0 经验分享：已经under review 3个月了，还是没有结果，最近这个杂志审稿这么慢吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6202174197, createdName=1205b465m15(暂无昵称), createdTime=Thu Feb 10 21:02:47 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192581, encodeId=ef2c1192581eb, content=请问投完稿是要等所有作者确认后才能开始审稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoia8XBibt7nbkfNowiberE3oPQDI0UaP5xKwibkVjYXyypsTh8ZPqqkQqicDpto5CjtKHdO3keDQf399w/132, createdBy=54a378415, createdName=Tacid, createdTime=Sat Feb 12 06:57:12 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924446, encodeId=e1b8924446a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：审稿速度较快，reviewer非常专业和犀利，每个问题都一针见血。修稿时间充裕，只要努力满足reviewer所有意见，应该问题不大。editor稍稍有点磨蹭但很友好。ASGCT的official journal，21年2月即时IF已经10.9了，希望IF节节高升, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Sat Feb 13 13:50:38 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224804, encodeId=54de1224804f2, content=molecular therapy在肿瘤口碑怎么样？难度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Mon Jun 06 19:59:44 CST 2022, time=2022-06-06, status=1, ipAttribution=)]

2019-07-09 大帅比

我的文章投出去十几天才送审稿，审稿已经快一个月了，想问问大神们大概审稿要多久啊，要不要发邮件问问？

205 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092759, encodeId=fafb2092e594a, content=垃圾杂志，慎投！ 2022年3月份第一次投稿，一周送审，一个月拒。根据意见补了很多实验基本上都补了。 2022年9月再投，两周才到编辑手里，再过了两周直接拒。耽搁一个月，垃圾杂志，编辑没什么水准，大家慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b45477596, createdName=ms9000001700710365, createdTime=Sun Oct 09 23:30:42 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092124, encodeId=87812092124ee, content=“decision in process ”状态持续两个月了，目前状态仍没变，我也醉了，太慢了，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/9FvfglcsAUhibbMfzXkaojIdbGAyJoDbfzcwdBibkRB0zfCnoHNsKeU3FhVGfibEvAOU0MJib8YXDz0ozRRLq0MDZw/132, createdBy=b1175246524, createdName=Lily’s, createdTime=Thu Oct 06 19:22:56 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089721, encodeId=4bb42089e2180, content=请问这个杂志从起投到接收一般多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcbb6495932, createdName=ms9000001442827569, createdTime=Thu Sep 22 09:45:41 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573502, encodeId=30fa5e3502b4, content=我的文章投出去十几天才送审稿，审稿已经快一个月了，想问问大神们大概审稿要多久啊，要不要发邮件问问？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdcc5116745, createdName=大帅比, createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186366, encodeId=6a15118636612, content=请问大家投稿后不确认作者信息，影响稿件处理进程吗？？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/d83e222ca83744579abc7ae60aec94b4/d3ddb54b1ac74080bbe927391f78ad1a.jpg, createdBy=36415493698, createdName=志志呀, createdTime=Thu Jan 20 10:08:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187450, encodeId=3e3c118e4501a, content=提交之后多久能到编辑手里啊 Manuscript Submitted快一星期了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75b2502321, createdName=云墨天青, createdTime=Sun Jan 23 13:24:39 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192018, encodeId=3e05119201862, content=审稿速度:6.0 经验分享：已经under review 3个月了，还是没有结果，最近这个杂志审稿这么慢吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6202174197, createdName=1205b465m15(暂无昵称), createdTime=Thu Feb 10 21:02:47 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192581, encodeId=ef2c1192581eb, content=请问投完稿是要等所有作者确认后才能开始审稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoia8XBibt7nbkfNowiberE3oPQDI0UaP5xKwibkVjYXyypsTh8ZPqqkQqicDpto5CjtKHdO3keDQf399w/132, createdBy=54a378415, createdName=Tacid, createdTime=Sat Feb 12 06:57:12 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924446, encodeId=e1b8924446a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：审稿速度较快，reviewer非常专业和犀利，每个问题都一针见血。修稿时间充裕，只要努力满足reviewer所有意见，应该问题不大。editor稍稍有点磨蹭但很友好。ASGCT的official journal，21年2月即时IF已经10.9了，希望IF节节高升, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Sat Feb 13 13:50:38 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224804, encodeId=54de1224804f2, content=molecular therapy在肿瘤口碑怎么样？难度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Mon Jun 06 19:59:44 CST 2022, time=2022-06-06, status=1, ipAttribution=)]

2022-01-20 志志呀

请问大家投稿后不确认作者信息，影响稿件处理进程吗？？谢谢大家

64 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092759, encodeId=fafb2092e594a, content=垃圾杂志，慎投！ 2022年3月份第一次投稿，一周送审，一个月拒。根据意见补了很多实验基本上都补了。 2022年9月再投，两周才到编辑手里，再过了两周直接拒。耽搁一个月，垃圾杂志，编辑没什么水准，大家慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b45477596, createdName=ms9000001700710365, createdTime=Sun Oct 09 23:30:42 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092124, encodeId=87812092124ee, content=“decision in process ”状态持续两个月了，目前状态仍没变，我也醉了，太慢了，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/9FvfglcsAUhibbMfzXkaojIdbGAyJoDbfzcwdBibkRB0zfCnoHNsKeU3FhVGfibEvAOU0MJib8YXDz0ozRRLq0MDZw/132, createdBy=b1175246524, createdName=Lily’s, createdTime=Thu Oct 06 19:22:56 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089721, encodeId=4bb42089e2180, content=请问这个杂志从起投到接收一般多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcbb6495932, createdName=ms9000001442827569, createdTime=Thu Sep 22 09:45:41 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573502, encodeId=30fa5e3502b4, content=我的文章投出去十几天才送审稿，审稿已经快一个月了，想问问大神们大概审稿要多久啊，要不要发邮件问问？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdcc5116745, createdName=大帅比, createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186366, encodeId=6a15118636612, content=请问大家投稿后不确认作者信息，影响稿件处理进程吗？？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/d83e222ca83744579abc7ae60aec94b4/d3ddb54b1ac74080bbe927391f78ad1a.jpg, createdBy=36415493698, createdName=志志呀, createdTime=Thu Jan 20 10:08:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187450, encodeId=3e3c118e4501a, content=提交之后多久能到编辑手里啊 Manuscript Submitted快一星期了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75b2502321, createdName=云墨天青, createdTime=Sun Jan 23 13:24:39 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192018, encodeId=3e05119201862, content=审稿速度:6.0 经验分享：已经under review 3个月了，还是没有结果，最近这个杂志审稿这么慢吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6202174197, createdName=1205b465m15(暂无昵称), createdTime=Thu Feb 10 21:02:47 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192581, encodeId=ef2c1192581eb, content=请问投完稿是要等所有作者确认后才能开始审稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoia8XBibt7nbkfNowiberE3oPQDI0UaP5xKwibkVjYXyypsTh8ZPqqkQqicDpto5CjtKHdO3keDQf399w/132, createdBy=54a378415, createdName=Tacid, createdTime=Sat Feb 12 06:57:12 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924446, encodeId=e1b8924446a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：审稿速度较快，reviewer非常专业和犀利，每个问题都一针见血。修稿时间充裕，只要努力满足reviewer所有意见，应该问题不大。editor稍稍有点磨蹭但很友好。ASGCT的official journal，21年2月即时IF已经10.9了，希望IF节节高升, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Sat Feb 13 13:50:38 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224804, encodeId=54de1224804f2, content=molecular therapy在肿瘤口碑怎么样？难度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Mon Jun 06 19:59:44 CST 2022, time=2022-06-06, status=1, ipAttribution=)]

2022-01-23 云墨天青

提交之后多久能到编辑手里啊 Manuscript Submitted快一星期了

76 15

展开15条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092759, encodeId=fafb2092e594a, content=垃圾杂志，慎投！ 2022年3月份第一次投稿，一周送审，一个月拒。根据意见补了很多实验基本上都补了。 2022年9月再投，两周才到编辑手里，再过了两周直接拒。耽搁一个月，垃圾杂志，编辑没什么水准，大家慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b45477596, createdName=ms9000001700710365, createdTime=Sun Oct 09 23:30:42 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092124, encodeId=87812092124ee, content=“decision in process ”状态持续两个月了，目前状态仍没变，我也醉了，太慢了，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/9FvfglcsAUhibbMfzXkaojIdbGAyJoDbfzcwdBibkRB0zfCnoHNsKeU3FhVGfibEvAOU0MJib8YXDz0ozRRLq0MDZw/132, createdBy=b1175246524, createdName=Lily’s, createdTime=Thu Oct 06 19:22:56 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089721, encodeId=4bb42089e2180, content=请问这个杂志从起投到接收一般多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcbb6495932, createdName=ms9000001442827569, createdTime=Thu Sep 22 09:45:41 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573502, encodeId=30fa5e3502b4, content=我的文章投出去十几天才送审稿，审稿已经快一个月了，想问问大神们大概审稿要多久啊，要不要发邮件问问？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdcc5116745, createdName=大帅比, createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186366, encodeId=6a15118636612, content=请问大家投稿后不确认作者信息，影响稿件处理进程吗？？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/d83e222ca83744579abc7ae60aec94b4/d3ddb54b1ac74080bbe927391f78ad1a.jpg, createdBy=36415493698, createdName=志志呀, createdTime=Thu Jan 20 10:08:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187450, encodeId=3e3c118e4501a, content=提交之后多久能到编辑手里啊 Manuscript Submitted快一星期了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75b2502321, createdName=云墨天青, createdTime=Sun Jan 23 13:24:39 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192018, encodeId=3e05119201862, content=审稿速度:6.0 经验分享：已经under review 3个月了，还是没有结果，最近这个杂志审稿这么慢吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6202174197, createdName=1205b465m15(暂无昵称), createdTime=Thu Feb 10 21:02:47 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192581, encodeId=ef2c1192581eb, content=请问投完稿是要等所有作者确认后才能开始审稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoia8XBibt7nbkfNowiberE3oPQDI0UaP5xKwibkVjYXyypsTh8ZPqqkQqicDpto5CjtKHdO3keDQf399w/132, createdBy=54a378415, createdName=Tacid, createdTime=Sat Feb 12 06:57:12 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924446, encodeId=e1b8924446a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：审稿速度较快，reviewer非常专业和犀利，每个问题都一针见血。修稿时间充裕，只要努力满足reviewer所有意见，应该问题不大。editor稍稍有点磨蹭但很友好。ASGCT的official journal，21年2月即时IF已经10.9了，希望IF节节高升, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Sat Feb 13 13:50:38 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224804, encodeId=54de1224804f2, content=molecular therapy在肿瘤口碑怎么样？难度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Mon Jun 06 19:59:44 CST 2022, time=2022-06-06, status=1, ipAttribution=)]

2022-02-10 1205b465m15(暂无昵称)

审稿速度:6.0
经验分享：已经under review 3个月了，还是没有结果，最近这个杂志审稿这么慢吗

49 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092759, encodeId=fafb2092e594a, content=垃圾杂志，慎投！ 2022年3月份第一次投稿，一周送审，一个月拒。根据意见补了很多实验基本上都补了。 2022年9月再投，两周才到编辑手里，再过了两周直接拒。耽搁一个月，垃圾杂志，编辑没什么水准，大家慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b45477596, createdName=ms9000001700710365, createdTime=Sun Oct 09 23:30:42 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092124, encodeId=87812092124ee, content=“decision in process ”状态持续两个月了，目前状态仍没变，我也醉了，太慢了，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/9FvfglcsAUhibbMfzXkaojIdbGAyJoDbfzcwdBibkRB0zfCnoHNsKeU3FhVGfibEvAOU0MJib8YXDz0ozRRLq0MDZw/132, createdBy=b1175246524, createdName=Lily’s, createdTime=Thu Oct 06 19:22:56 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089721, encodeId=4bb42089e2180, content=请问这个杂志从起投到接收一般多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcbb6495932, createdName=ms9000001442827569, createdTime=Thu Sep 22 09:45:41 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573502, encodeId=30fa5e3502b4, content=我的文章投出去十几天才送审稿，审稿已经快一个月了，想问问大神们大概审稿要多久啊，要不要发邮件问问？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdcc5116745, createdName=大帅比, createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186366, encodeId=6a15118636612, content=请问大家投稿后不确认作者信息，影响稿件处理进程吗？？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/d83e222ca83744579abc7ae60aec94b4/d3ddb54b1ac74080bbe927391f78ad1a.jpg, createdBy=36415493698, createdName=志志呀, createdTime=Thu Jan 20 10:08:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187450, encodeId=3e3c118e4501a, content=提交之后多久能到编辑手里啊 Manuscript Submitted快一星期了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75b2502321, createdName=云墨天青, createdTime=Sun Jan 23 13:24:39 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192018, encodeId=3e05119201862, content=审稿速度:6.0 经验分享：已经under review 3个月了，还是没有结果，最近这个杂志审稿这么慢吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6202174197, createdName=1205b465m15(暂无昵称), createdTime=Thu Feb 10 21:02:47 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192581, encodeId=ef2c1192581eb, content=请问投完稿是要等所有作者确认后才能开始审稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoia8XBibt7nbkfNowiberE3oPQDI0UaP5xKwibkVjYXyypsTh8ZPqqkQqicDpto5CjtKHdO3keDQf399w/132, createdBy=54a378415, createdName=Tacid, createdTime=Sat Feb 12 06:57:12 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924446, encodeId=e1b8924446a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：审稿速度较快，reviewer非常专业和犀利，每个问题都一针见血。修稿时间充裕，只要努力满足reviewer所有意见，应该问题不大。editor稍稍有点磨蹭但很友好。ASGCT的official journal，21年2月即时IF已经10.9了，希望IF节节高升, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Sat Feb 13 13:50:38 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224804, encodeId=54de1224804f2, content=molecular therapy在肿瘤口碑怎么样？难度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Mon Jun 06 19:59:44 CST 2022, time=2022-06-06, status=1, ipAttribution=)]

2022-02-12 Tacid

请问投完稿是要等所有作者确认后才能开始审稿吗

56 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092759, encodeId=fafb2092e594a, content=垃圾杂志，慎投！ 2022年3月份第一次投稿，一周送审，一个月拒。根据意见补了很多实验基本上都补了。 2022年9月再投，两周才到编辑手里，再过了两周直接拒。耽搁一个月，垃圾杂志，编辑没什么水准，大家慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b45477596, createdName=ms9000001700710365, createdTime=Sun Oct 09 23:30:42 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092124, encodeId=87812092124ee, content=“decision in process ”状态持续两个月了，目前状态仍没变，我也醉了，太慢了，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/9FvfglcsAUhibbMfzXkaojIdbGAyJoDbfzcwdBibkRB0zfCnoHNsKeU3FhVGfibEvAOU0MJib8YXDz0ozRRLq0MDZw/132, createdBy=b1175246524, createdName=Lily’s, createdTime=Thu Oct 06 19:22:56 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089721, encodeId=4bb42089e2180, content=请问这个杂志从起投到接收一般多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcbb6495932, createdName=ms9000001442827569, createdTime=Thu Sep 22 09:45:41 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573502, encodeId=30fa5e3502b4, content=我的文章投出去十几天才送审稿，审稿已经快一个月了，想问问大神们大概审稿要多久啊，要不要发邮件问问？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdcc5116745, createdName=大帅比, createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186366, encodeId=6a15118636612, content=请问大家投稿后不确认作者信息，影响稿件处理进程吗？？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/d83e222ca83744579abc7ae60aec94b4/d3ddb54b1ac74080bbe927391f78ad1a.jpg, createdBy=36415493698, createdName=志志呀, createdTime=Thu Jan 20 10:08:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187450, encodeId=3e3c118e4501a, content=提交之后多久能到编辑手里啊 Manuscript Submitted快一星期了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75b2502321, createdName=云墨天青, createdTime=Sun Jan 23 13:24:39 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192018, encodeId=3e05119201862, content=审稿速度:6.0 经验分享：已经under review 3个月了，还是没有结果，最近这个杂志审稿这么慢吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6202174197, createdName=1205b465m15(暂无昵称), createdTime=Thu Feb 10 21:02:47 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192581, encodeId=ef2c1192581eb, content=请问投完稿是要等所有作者确认后才能开始审稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoia8XBibt7nbkfNowiberE3oPQDI0UaP5xKwibkVjYXyypsTh8ZPqqkQqicDpto5CjtKHdO3keDQf399w/132, createdBy=54a378415, createdName=Tacid, createdTime=Sat Feb 12 06:57:12 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924446, encodeId=e1b8924446a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：审稿速度较快，reviewer非常专业和犀利，每个问题都一针见血。修稿时间充裕，只要努力满足reviewer所有意见，应该问题不大。editor稍稍有点磨蹭但很友好。ASGCT的official journal，21年2月即时IF已经10.9了，希望IF节节高升, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Sat Feb 13 13:50:38 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224804, encodeId=54de1224804f2, content=molecular therapy在肿瘤口碑怎么样？难度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Mon Jun 06 19:59:44 CST 2022, time=2022-06-06, status=1, ipAttribution=)]

2021-02-13 dr_NEO

审稿速度:2.0 | 投稿命中率:5.0
经验分享：审稿速度较快，reviewer非常专业和犀利，每个问题都一针见血。修稿时间充裕，只要努力满足reviewer所有意见，应该问题不大。editor稍稍有点磨蹭但很友好。ASGCT的official journal，21年2月即时IF已经10.9了，希望IF节节高升

399 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2092759, encodeId=fafb2092e594a, content=垃圾杂志，慎投！ 2022年3月份第一次投稿，一周送审，一个月拒。根据意见补了很多实验基本上都补了。 2022年9月再投，两周才到编辑手里，再过了两周直接拒。耽搁一个月，垃圾杂志，编辑没什么水准，大家慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b45477596, createdName=ms9000001700710365, createdTime=Sun Oct 09 23:30:42 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092124, encodeId=87812092124ee, content=“decision in process ”状态持续两个月了，目前状态仍没变，我也醉了，太慢了，太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/9FvfglcsAUhibbMfzXkaojIdbGAyJoDbfzcwdBibkRB0zfCnoHNsKeU3FhVGfibEvAOU0MJib8YXDz0ozRRLq0MDZw/132, createdBy=b1175246524, createdName=Lily’s, createdTime=Thu Oct 06 19:22:56 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089721, encodeId=4bb42089e2180, content=请问这个杂志从起投到接收一般多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcbb6495932, createdName=ms9000001442827569, createdTime=Thu Sep 22 09:45:41 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573502, encodeId=30fa5e3502b4, content=我的文章投出去十几天才送审稿，审稿已经快一个月了，想问问大神们大概审稿要多久啊，要不要发邮件问问？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdcc5116745, createdName=大帅比, createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186366, encodeId=6a15118636612, content=请问大家投稿后不确认作者信息，影响稿件处理进程吗？？谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/d83e222ca83744579abc7ae60aec94b4/d3ddb54b1ac74080bbe927391f78ad1a.jpg, createdBy=36415493698, createdName=志志呀, createdTime=Thu Jan 20 10:08:21 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187450, encodeId=3e3c118e4501a, content=提交之后多久能到编辑手里啊 Manuscript Submitted快一星期了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c75b2502321, createdName=云墨天青, createdTime=Sun Jan 23 13:24:39 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192018, encodeId=3e05119201862, content=审稿速度:6.0 经验分享：已经under review 3个月了，还是没有结果，最近这个杂志审稿这么慢吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6202174197, createdName=1205b465m15(暂无昵称), createdTime=Thu Feb 10 21:02:47 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192581, encodeId=ef2c1192581eb, content=请问投完稿是要等所有作者确认后才能开始审稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoia8XBibt7nbkfNowiberE3oPQDI0UaP5xKwibkVjYXyypsTh8ZPqqkQqicDpto5CjtKHdO3keDQf399w/132, createdBy=54a378415, createdName=Tacid, createdTime=Sat Feb 12 06:57:12 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924446, encodeId=e1b8924446a0, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：审稿速度较快，reviewer非常专业和犀利，每个问题都一针见血。修稿时间充裕，只要努力满足reviewer所有意见，应该问题不大。editor稍稍有点磨蹭但很友好。ASGCT的official journal，21年2月即时IF已经10.9了，希望IF节节高升, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211125/3ed6e6b85cb94850bc6d5c9196d9515b/fa7ea09f297a4ff3ac3a8b97cd364368.jpg, createdBy=e2885122441, createdName=dr_NEO, createdTime=Sat Feb 13 13:50:38 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224804, encodeId=54de1224804f2, content=molecular therapy在肿瘤口碑怎么样？难度如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Mon Jun 06 19:59:44 CST 2022, time=2022-06-06, status=1, ipAttribution=)]

2022-06-06 ms3000000242801209

molecular therapy在肿瘤口碑怎么样？难度如何

39 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务